Metagenomics, based on next-generation sequencing (NGS), has been available for a decade and is now widely used for research purposes. In parallel, clinicians are currently paying a growing interest in how NGS could help in the diagnosis and management of several diseases. In the field of infectious diseases, metagenomics has demonstrated its potential in the identification of pathogens and the inference of the antibiotic susceptibility profiles of bacteria. On a broader perspective, metagenomics of the intestinal microbiota has opened several opportunities in various clinical fields such as obesity, autism and cancer.
Last year was a remarkable success with more than 170 attendees from more than 20 countries, and a very high-quality scientific program, confirming ICCMg as a major place to discuss clinical metagenomics. The main messages from the second ICCMg have recently been published in the Microbe and Infections journal.
This year, join us at the third International Conference on Clinical Metagenomics on October 18-19, 2018 in Geneva.
More than ever, ICCMg is intended to be organized on a yearly basis. For ICCMg3, we aim at keeping a high-quality program with keynotes given by the current leaders in clinical metagenomics, but also to maintain slots for oral presentations to selected abstracts.
The main sessions for this ICCMg3 will focus on the microbiota and personalized medicine, the contribution of clinical metagenomics in the outbreak context and on the potential of circulating free DNA in the diagnostic of bacteremia. Besides, we will hold a session on “clinical genomics” since the use of NGS in routine laboratories is coming in the short term: http://clinicalmetagenomics.org/
Events